Literature DB >> 19264453

A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene.

Yanglong Zhu1, Ted Kalbfleisch, Mark D Brennan, Yong Li.   

Abstract

Schizophrenia (SZ) is a neuropsychiatric disorder that affects about 1% of the adult population. Numerous genes have been implicated in SZ susceptibility. MicroRNAs (miRNA) are small RNA molecules that regulate the translation of mRNAs via interactions with their 3' untranslated regions. Identification of known miRNA targets on all human genes indicated that miRNA-346 targets SZ susceptibility genes listed in the SchizophreniaGene database twice as frequently as expected relative to other genes in the genome. The gene encoding this miRNA, miR-346, is located in intron 2 of the glutamate receptor ionotropic delta 1 (GRID1) gene, which has been previously implicated in SZ susceptibility. We used quantitative real-time PCR to determine the expression levels of miR-346 and GRID1 using brain RNA samples from the Stanley Array Collection, Stanley Medical Research Institute. Expression of both miR-346 and GRID1 is lower in SZ patients than that in normal controls (P=0.017 and 0.086, respectively). However, the expression of miR-346 and GRID1 is less correlated in SZ patients than in bipolar patients or in normal controls. This study implicates the importance of a miRNA in SZ.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264453      PMCID: PMC2664103          DOI: 10.1016/j.schres.2009.01.022

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  15 in total

1.  Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia.

Authors:  Stephen J Glatt; Ian P Everall; William S Kremen; Jacques Corbeil; Roman Sásik; Negar Khanlou; Mark Han; Choong-Chin Liew; Ming T Tsuang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-13       Impact factor: 11.205

2.  Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex.

Authors:  Jinju Han; Yoontae Lee; Kyu-Hyeon Yeom; Jin-Wu Nam; Inha Heo; Je-Keun Rhee; Sun Young Sohn; Yunje Cho; Byoung-Tak Zhang; V Narry Kim
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

Review 3.  Schizophrenia: genes at last?

Authors:  M J Owen; N Craddock; M C O'Donovan
Journal:  Trends Genet       Date:  2005-09       Impact factor: 11.639

4.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia.

Authors:  Y Hakak; J R Walker; C Li; W H Wong; K L Davis; J D Buxbaum; V Haroutunian; A A Fienberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

5.  Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios.

Authors:  M Daniele Fallin; Virginia K Lasseter; Dimitrios Avramopoulos; Kristin K Nicodemus; Paula S Wolyniec; John A McGrath; Gary Steel; Gerald Nestadt; Kung-Yee Liang; Richard L Huganir; David Valle; Ann E Pulver
Journal:  Am J Hum Genet       Date:  2005-10-28       Impact factor: 11.025

6.  Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex.

Authors:  K Mirnics; F A Middleton; A Marquez; D A Lewis; P Levitt
Journal:  Neuron       Date:  2000-10       Impact factor: 17.173

7.  A case-control association study between the GRID1 gene and schizophrenia in the Chinese Northern Han population.

Authors:  Sheng-Zhen Guo; Ke Huang; Yong-Yong Shi; Wei Tang; Jian Zhou; Guo-Yin Feng; Shao-Min Zhu; Hui-Jun Liu; Yi Chen; Xiao-Dong Sun; Lin He
Journal:  Schizophr Res       Date:  2007-05-09       Impact factor: 4.939

8.  Genomic analysis of human microRNA transcripts.

Authors:  Harpreet Kaur Saini; Sam Griffiths-Jones; Anton James Enright
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-26       Impact factor: 11.205

Review 9.  Finding schizophrenia genes.

Authors:  George Kirov; Michael C O'Donovan; Michael J Owen
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

10.  microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder.

Authors:  Diana O Perkins; Clark D Jeffries; L Fredrik Jarskog; J Michael Thomson; Keith Woods; Martin A Newman; Joel S Parker; Jianping Jin; Scott M Hammond
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  47 in total

Review 1.  MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.

Authors:  Andrea de Bartolomeis; Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro
Journal:  Mol Neurobiol       Date:  2014-11-14       Impact factor: 5.590

Review 2.  Heterogeneity and individuality: microRNAs in mental disorders.

Authors:  Leif G Hommers; Katharina Domschke; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2014-11-14       Impact factor: 3.575

Review 3.  Evidence demonstrating role of microRNAs in the etiopathology of major depression.

Authors:  Yogesh Dwivedi
Journal:  J Chem Neuroanat       Date:  2011-04-14       Impact factor: 3.052

4.  In vivo microRNA detection and quantitation in cerebrospinal fluid.

Authors:  Juan A Gallego; Marc L Gordon; Kierstyn Claycomb; Mahima Bhatt; Todd Lencz; Anil K Malhotra
Journal:  J Mol Neurosci       Date:  2012-03-09       Impact factor: 3.444

5.  The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes.

Authors:  Rafal Bartoszewski; Joseph W Brewer; Andras Rab; David K Crossman; Sylwia Bartoszewska; Niren Kapoor; Cathy Fuller; James F Collawn; Zsuzsa Bebok
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

Review 6.  MicroRNAs in neuronal communication.

Authors:  Guilherme Shigueto Vilar Higa; Erica de Sousa; Lais Takata Walter; Erika Reime Kinjo; Rodrigo Ribeiro Resende; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2014-01-03       Impact factor: 5.590

7.  The phenotype of recurrent 10q22q23 deletions and duplications.

Authors:  Bregje W M van Bon; Jorune Balciuniene; Gary Fruhman; Sandesh Chakravarthy Sreenath Nagamani; Diane L Broome; Elizabeth Cameron; Danielle Martinet; Eliane Roulet; Sebastien Jacquemont; Jacques S Beckmann; Mira Irons; Lorraine Potocki; Brendan Lee; Sau Wai Cheung; Ankita Patel; Melissa Bellini; Angelo Selicorni; Roberto Ciccone; Margherita Silengo; Annalisa Vetro; Nine V Knoers; Nicole de Leeuw; Rolph Pfundt; Barry Wolf; Petr Jira; Swaroop Aradhya; Pawel Stankiewicz; Han G Brunner; Orsetta Zuffardi; Scott B Selleck; James R Lupski; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

Review 8.  The miRNA pathway in neurological and skeletal muscle disease: implications for pathogenesis and therapy.

Authors:  Christopher R Sibley; Matthew J A Wood
Journal:  J Mol Med (Berl)       Date:  2011-07-13       Impact factor: 4.599

Review 9.  MicroRNAs in addiction: adaptation's middlemen?

Authors:  M D Li; A D van der Vaart
Journal:  Mol Psychiatry       Date:  2011-05-24       Impact factor: 15.992

Review 10.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.